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Introduction
============

Intracellular membrane trafficking is a highly regulated process ([@bib26]). SNAREs play a critical role in this process by regulating membrane docking and fusion ([@bib26]; [@bib29]). Transport vesicles contain membrane proteins (v-SNAREs), which specifically bind to cognate membrane proteins (t-SNAREs) in the appropriate target membrane. Large families of v- and t-SNARE proteins have been identified in eukaryotic cells with different members localizing to different compartments ([@bib26]). The correct pairing of v- and t-SNAREs in opposing membranes is defined by the formation of a stable high affinity complex referred to as the trans- or SNARE core complex ([@bib19]; [@bib27]; [@bib29]). v- and t-SNAREs contain α-helical domains that contribute to a four-helix bundle giving rise to the SNARE complex ([@bib27]).

SNARE complex assembly occurs in several discrete stages. Initially, in a priming step, cis-SNARE complexes in both donor and target membranes are disassembled through the ATPase action of NSF in conjunction with its attachment protein α-SNAP ([@bib17]). Once primed, tethering machinery may guide the SNAREs in each membrane into close proximity and a proofreading machinery likely ensures fidelity of the aligned v- and t-SNARE pairs ([@bib33]). Formation of the high affinity trans-SNARE complex represents the committed step of docking ([@bib28]). This step is accompanied by conversion of trans- to cis-complexes ([@bib15]; [@bib27]). Although SNARE proteins are sufficient to catalyze docking and fusion of artificial membrane liposomes in vitro ([@bib29]; [@bib18]), other factors are essential in vivo, suggesting multiple levels of regulation.

The Sec1p/Munc18 (SM)[\*](#fn1){ref-type="fn"} family plays an essential role in regulating membrane transport ([@bib12]). Disruption or deletion of any of the four SM proteins in *Saccharomyces cerevisiae* causes a block in vesicle transport ([@bib12]). SM proteins are peripheral membrane proteins. We have demonstrated previously that the SM protein Vps45p is dependent on its cognate t-SNARE Tlg2p for its membrane association ([@bib2]). Moreover, it has been shown that many SM proteins bind their cognate t-SNARE with high affinity in vitro ([@bib23]; [@bib31]), suggesting that the stable association of SM proteins with membranes is mediated via this interaction. But how this interaction changes as the t-SNARE engages in core complex assembly during docking is not known. At the neuronal synapse, it is thought that the SM protein Munc18a is inhibitory to core complex assembly and that its dissociation from the t-SNARE is required to promote this process ([@bib22]). Neither the fate of the liberated SM protein, or the mechanism that underlies its dissociation is known. One possibility is that SM proteins dissociate from membranes before core assembly. Intriguingly, many SM proteins, including Vps45p are present as both cytosolic and membrane-bound forms ([@bib5]; [@bib2]). The cytosolic pool may represent newly synthesized protein or Vps45p that has been discharged from the membrane during vesicle transport. In either case, it is not clear at what stage SM proteins achieve their membrane association. Intriguingly, Sec1p is found stably associated with the cis-SNARE complex ([@bib4]), suggesting that the terminal stage of the transport reaction may be the point at which SM proteins reassociate with the membrane in order to reactivate the t-SNARE for another round of vesicle transport.

Here, we have found that the SM protein Vps45p dissociates from membranes before fusion and reassociates after fusion probably by binding to a cis-SNARE complex. The cyclical membrane association of Vps45p is temporally linked to the docking--fusion stage of vesicle transport at a step controlled by the protein phosphatase Glc7p. We propose that the dissociation of SM proteins from the membrane may be controlled by phosphorylation and that this family of proteins may act as molecular switches to control SNARE complex assembly.

Results and discussion
======================

Vps45p binds to monomeric Tlg2p and to the cis-SNARE--core complex
------------------------------------------------------------------

We have demonstrated previously that Vps45p binds to Tlg2p both in vitro and in vivo ([@bib2]). Other SM proteins, including Sly1p and Sec1p, bind to their respective SNARE complexes ([@bib13]; [@bib4]; [@bib20]). Importantly, Sec1p binds to the cis-core complex, indicating a role for SM proteins after vesicle fusion ([@bib10]). To determine whether Vps45p binds to the Tlg2p-containing core complex, we took advantage of cells harboring the temperature-sensitive *sec18--1* mutation. Sec18p is an ATPase that catalyses the disassembly of SNARE complexes so that they can be recycled for further rounds of vesicle transport ([@bib17]). At the restrictive temperature (37°C), the mutant Sec18--1p is deficient in this ATPase activity and *sec18--1* cells, thus, accumulate cis-SNARE complexes ([@bib10]). Consistent with this, we observed a significant increase in the accumulation of cis-Tlg2p--Tlg1p--Vti1p--Snc2p SNARE complexes in *sec18--1* cells placed at the nonpermissive temperature (37°C). [Fig. 1](#fig1){ref-type="fig"} demonstrates that there is a five- to sevenfold increase in the amount of Tlg2p, Vti1p, and Snc2p that coprecipitate with Tlg1p under these conditions. Commensurate with the increase in SNARE complexes, we observed a fivefold increase in the amount of Vps45p that coprecipitated with Tlg1p. As we have previously demonstrated that Vps45p does not bind directly to Tlg1p ([@bib2]), these data indicate that Vps45p, like Sec1p ([@bib4]) and Sly1p ([@bib14]; [@bib20]), binds to its cognate SNARE complex. Given that, we observed the association of Vps45p with SNARE complexes in *sec18--1* cells, this likely corresponds to an association with cis-complexes, and is in agreement with previous studies ([@bib4]; [@bib10]).

![**Vps45p binds to cis-Tlg1p--Tlg2p--Vti1p--Snc2p SNARE complexes that accumulate upon inactivation of** *SEC18* **.** Tlg1p-containing complexes were immunoprecipitated from the wild-type (WT) cells (NOzY21) or *sec18--1* cells (NOzY22) grown at 25°C (25°C), or grown at 25°C, and then incubated at 37°C for 10 min before cell lysate preparation (37°C). Immunoblot analysis was used to detect the amount of Tlg1p, Tlg2p, Vti1p, HA-tagged Snc2p, and Vps45p in the immunoprecipitated complexes.](200212078f1){#fig1}

We, and others, have shown that Vps45p binds to monomeric Tlg2p in vitro ([@bib2]; [@bib6]; [@bib31]). The observation that Sec1p binds to Ssop-containing SNARE complexes, but not to the monomeric t-SNARE ([@bib4]), raises the possibility that the association observed between Tlg2p and Vps45p in vivo does not reflect the SM protein binding to the monomeric t-SNARE, but rather to the cis-SNARE complex. This is the case for the interaction between Sec1p and Ssop ([@bib4]), as demonstrated by the lack of interaction between these two proteins in *sec4--8* cells ([@bib4]). *SEC4* encodes the Rab protein involved in the fusion of secretory vesicles with the plasma membrane, and *sec4--8* cells are defective in assembly of Ssop SNARE complexes ([@bib9]). The Rab protein involved in *VPS45*-dependent membrane transport is encoded by *VPS21* ([@bib8]). [Fig. 2](#fig2){ref-type="fig"} shows that Tlg1p was not found in complex with its SNARE binding partners in *vps21*Δ mutant cells. Under these conditions, Tlg1p no longer coprecipitated Vps45p ([Fig. 2](#fig2){ref-type="fig"} A). Importantly, Vps45p was still found in complex with Tlg2p in *vps21*Δ cells ([Fig. 2](#fig2){ref-type="fig"} B). These data demonstrate that Vps45p binds to the monomeric t-SNARE Tlg2p, and to the cis-Tlg2p--Tlg1p--Vti1p--Snc2p SNARE complex in vivo.

![**Vps45p binds to Tlg2p in isolation from its SNARE binding partners.** (A) Tlg1p- and (B) Tlg2p-containing complexes were immunoprecipitated from the wild-type (WT) (NOzY21) or *vps21*Δ (NOzY24) cells. Immunoblot analysis was used to detect the amount of Tlg1p, Tlg2p, Vti1p, HA-tagged Snc2p, and Vps45p in the immunoprecipitated complexes as indicated.](200212078f2){#fig2}

Our finding that Vps45p binds to both monomeric Tlg2p and to the cis-core complex may indicate that the interaction between this SM protein and the t-SNARE is maintained throughout the SNARE cycle. To test this model, and further characterize the interaction between Vps45p and its cognate SNARE complex, we set out to assess the ability of Vps45p to bind to a trans-SNARE complex. To generate trans-SNARE complexes in vivo we endeavored to find a mutant that blocks membrane transport between vesicle docking and bilayer fusion. One protein that has been implicated at this stage is protein phosphatase 1 (PP1). PP1 (Glc7p) has been shown to function at a late stage of vacuole fusion, likely during the bilayer mixing phase ([@bib21]). A cell-free assay that reconstitutes homotypic vacuolar fusion has been used to define discrete stages in this reaction ([@bib30]). Inhibition of either Rab or SNARE function blocks at an early stage in this assay ([@bib30]). In contrast, inhibition of PP1 using either microcystin or temperature-sensitive alleles of *GLC7* block at a very late stage after docking ([@bib21]). In addition to vacuolar fusion, it has also been shown that PP1 is involved in multiple intracellular fusion steps, including ER to Golgi complex transport and endocytic traffic ([@bib21]). This suggests that PP1 is a general component of the membrane fusion machinery that, like Sec18p, operates in all vesicle transport reactions ([@bib21]). One prediction from the model that PP1 (Glc7p) is involved at a late, postdocking stage of membrane fusion is that inhibition of PP1 action results in an accumulation of trans-SNARE complexes ([@bib21]).

[Fig. 3](#fig3){ref-type="fig"} demonstrates that there is a significant three- to fivefold increase in the amount of Tlg2p, Vti1p, and Snc2p that coprecipitate with Tlg1p when cells harboring a temperature-sensitive allele of *GLC7* are incubated at the nonpermissive temperature ([Fig. 3](#fig3){ref-type="fig"} A). Intriguingly, no Vps45p was found associated with the SNARE complexes that accumulate in these cells ([Fig. 3](#fig3){ref-type="fig"} A, 37°C). This is in contrast to the cis-SNARE complexes that accumulate in *sec18--1* cells ([Fig. 1](#fig1){ref-type="fig"}). The observation that Vps45p binds to SNARE complexes present in wild-type cells, and also to those detected in *sec18--1* cells at the permissive temperature, indicates that these are cis-SNARE complexes, whereas those that accumulate in *glc7--10* cells at 37°C are in the trans-configuration.

![**Vps45p loses membrane association upon inactivation of PP1.** (A) Tlg1p-containing complexes were immunoprecipitated from cells harboring the *glc7--10* mutation (NOzY23) grown at 25°C (25°C), or grown at 25°C and then incubated at 37°C for 10 min before cell lysate preparation (37°C). Immunoblot analysis was used to detect the amount of Tlg1p, Tlg2p, Vti1p, HA-tagged Snc2p, and Vps45p in the immunoprecipitated complexes. (B) wild-type (SF838--9D), *sec18--1* (NOzY22), *vps21*Δ (SGY79), and *glc7--10* (PAY704--1) cells were incubated at 37°C for 10 min before fractionation by differential centrifugation to yield a whole cell extract (WCE), a low-speed membrane pellet (P13), a high-speed membrane pellet (P100), and a soluble, cytosolic fraction (S100). The amount of Vps45p in each fraction was assessed using immunoblot analysis.](200212078f3){#fig3}

The above data raises important questions concerning SM protein function. If Vps45p dissociates from the trans-SNARE complex upon vesicle docking, does it remain membrane associated during this stage? To address this, we assessed the membrane association of Vps45p in wild-type, *vps21*Δ, *sec18--1*, and *glc7--10* cells ([Fig. 3](#fig3){ref-type="fig"} B). Consistent with previous studies, the majority of Vps45p was associated with membranes in wild-type cells ([@bib5]; [@bib2]). Vps45p retained its membrane localization in cells lacking *VPS21*, which are defective in SNARE complex assembly, presumably through its interaction with monomeric Tlg2p ([@bib2]; [Fig. 2](#fig2){ref-type="fig"}). Similarly, the SM protein was associated with membranes in *sec18--1* cells at 37°C ([Fig. 3](#fig3){ref-type="fig"} B). However, strikingly, Vps45p was not found associated with membranes in *glc7--10* cells at 37°C, but rather localized to the cytosol ([Fig. 3](#fig3){ref-type="fig"} B). These data are consistent with our observation that Vps45p binds to the SNARE complexes that accumulate in *sec18--1* cells ([Fig. 1](#fig1){ref-type="fig"}), but not to those that accumulate in *glc7--10* cells at 37°C ([Fig. 3](#fig3){ref-type="fig"} A).

To assess the physiological relevance of the loss of membrane association upon inactivation of PP1, we sought to ascertain whether the dissociation observed upon inactivation of PP1 was reversible upon reactivation of the phosphatase. [Fig. 4](#fig4){ref-type="fig"} A demonstrates that the block in membrane trafficking caused by incubation of *glc7--10* cells is reversible. It has been shown previously that the transit of the vacuolar hydrolase carboxypeptidase Y (CPY) through the secretory pathway is blocked in PP1 temperature-sensitive cells at 37°C ([@bib21]). After its synthesis, CPY is translocated into the lumen of the ER, where it is core glycosylated into the p1 form. CPY receives further modifications as it transits through the Golgi apparatus. In the trans-Golgi network, the p2 form of CPY is recognized by its receptor Vps10p, which delivers the protein to the vacuole where it is cleaved into the mature form of the protease ([@bib3]). [Fig. 4](#fig4){ref-type="fig"} A demonstrates that incubation of *glc7--10* cells at 37°C blocks the processing of CPY. Concomitant with this block in vesicle fusion is the dissociation of Vps45p from membranes, as demonstrated by the observation that the SM protein shifts from the P100 (membrane) to the S100 (cytosol) fraction obtained from these cells after 10 min at 37°C ([Fig. 4](#fig4){ref-type="fig"} B). The block in processing of CPY was reversed by returning the cells to 24°C ([Fig. 4](#fig4){ref-type="fig"} A). Importantly, with this recovery in vesicular transport, Vps45p reassociated with membranes ([Fig. 4](#fig4){ref-type="fig"} B). These data indicate that the redistribution of Vps45p from membranes to the cytosol, observed in *glc7--10* cells ([Figs. 3](#fig3){ref-type="fig"} and [4](#fig4){ref-type="fig"}) represents a physiological intermediate.

![**Vps45p cycles on and off membranes during membrane transport.** Cells harboring the *glc7--10* mutation (PAY704--1) were grown overnight at 24°C. Cells were then either left at 24°C, shifted to 37°C for 10 min or shifted to 37°C for 10 min and moved back to 24°C for 1 h. (A) The fate of newly synthesized CPY in these cells was assessed by immunoprecipitation of the protein after metabolic labeling of cells. CPY was processed at the permissive (24°C), but not at the nonpermissive (37°C) temperature. Shown are cells incubated at 37°C for 10 min, but identical results were observed at longer incubation times (up to 60 min). CPY processing was restored when cells previously incubated at 37°C for 10 min were returned to the 25°C. (B) The membrane association of Vps45p in these cells was assessed by subcellular fractionation by differential centrifugation followed by immunoblot analysis.](200212078f4){#fig4}

The SNARE assembly cycle depicted in [Fig. 5](#fig5){ref-type="fig"} illustrates the dynamic equilibrium between the t-SNARE Tlg2p in its monomeric state, and as part of trans- and cis-complexes. Each one of these states defines an intermediate in the vesicle docking--fusion process. We have demonstrated that Vps45p binds to Tlg2p in this state before the formation of the trans-SNARE complex in a Rab (Vps21p)-dependent process ([@bib16]; [@bib9]). We show that Vps45p dissociates at this stage of the cycle and is released into the cytosol. The conversion of trans-SNARE complexes to the cis-configuration defines membrane fusion ([@bib28]), and also represents the starting point for another round of vesicle transport. It is here that Vps45p reenters the cycle by binding to the cis-complex. The cycle is completed after disassembly of cis-SNARE complexes with Vps45p bound by Sec18p presumably resulting in the Vps45p--Tlg2p complex that is then ready to receive incoming vesicles in the process of docking.

![**Model for the interaction of Vps45p with Tlg2p during SNARE complex assembly--disassembly.** Model depicting the association and dissociation of Vps45p with membranes at different stages of the SNARE assembly--disassembly cycle. The cycle begins with the t-SNARE/SM heterodimer (Tlg2p/Vps45p), which precedes the docking reaction involving the Rab protein Vps21p. Docking results in the formation of a trans-SNARE complex involving the v-SNARE on the transport vesicle and the t-SNAREs in the target membrane. The SNARE complex is found in a cis-configuration following merging of the two lipid bilayers during the fusion reaction (involving the protein phosphatase, Glc7p), and is subsequently disassembled by the ATPase, Sec18p. Vps45p dissociates from membranes either before or during formation of the trans-complex in concert with the action of the Rab protein and/or the phosphatase and then rebinds to the cis-SNARE complex.](200212078f5){#fig5}

The formation of unifying models concerning SM protein function has been made difficult by conflicting observations concerning their binding properties: Munc18a binds to monomeric Syntaxin1a, but not to SNARE complexes ([@bib32]). Sec1p binds to Ssop--SNARE complexes, but not to the monomeric t-SNARE ([@bib4]); although others, such as Sly1p, Munc18c, and now Vps45p, bind both to the monomeric t-SNARE and to the SNARE complex ([@bib14]; [@bib20]; unpublished data). Some of these differences may reflect the different conformations undertaken by these different proteins in vitro, but they may also represent kinetic differences at various stages of the cycle outlined in [Fig. 5](#fig5){ref-type="fig"} for different SNARE pairs. For example, in neurones there is an accumulation of predocked vesicles ([@bib26]), and therefore, presumably an accumulation of trans-SNARE complexes, whereas it is likely that the Sso-containing SNARE complexes observed in wild-type yeast cells are in the cis-configuration ([@bib10]).

In a manner similar to the finding that Sec1p binds to SNARE complexes ([@bib4]), we observed a robust interaction between Vps45p and Tlg2p in *sec18--1* cells ([Fig. 1](#fig1){ref-type="fig"}). It is noteworthy that in a previous study, [@bib16] reported that there was no significant interaction between Sly1p- and Sed5p-containing SNARE complexes that accumulate in *sec18--1* cells, despite the fact that Sly1p has subsequently been shown to interact with Sed5p-containing SNARE complexes formed in vitro ([@bib14]; [@bib20]). However, in that study ([@bib16]), *sec18--1* mutants were incubated for times significantly longer than those used here, and we have found that the period of incubation of these cells at the nonpermissive temperature is critical in these experiments (unpublished data).

Our model raises a number of important questions that provide a framework for further investigation directed at understanding the role of SM proteins. Why does Vps45p dissociate from the membrane during the docking--fusion stage? Do SM proteins play a role, similar to Rab proteins, and cycle on and off membranes in synchrony with the arrival of vesicles at the docking site? In addition, our paper raises questions concerning the role of PP1 in docking--fusion events. What is the role of phosphorylation that appears to be so intimately linked to the docking--fusion transition of vesicle transport; and is the dissociation of the SM protein during this phase the cause, or an effect, of this? Intriguingly, a role for the phosphorylation of Tlg2p has been implicated in modulating endocytosis ([@bib11]), and phosphorylation of Munc18a may be important in regulating its interaction with Syntaxin1a ([@bib7]). Finally, with our finding that Vps45p binds selectively to certain SNARE intermediates, could it be that there is a consensus in SM function that has been thus far difficult to realize? If phosphorylation plays an important role in the SM--SNARE interaction, replicating the conditions necessary to establish these interactions may not be trivial. Notably, [@bib4] stressed the importance of eliminating ATP from their cells before isolation of intact SNARE complexes. Answers to the above, and other, questions will further our understanding of this important family of proteins.

Materials and methods
=====================

Antibodies
----------

Rabbit polyclonal antibodies against Tlg2p and Vps45p have been described previously ([@bib2]). Antibodies that specifically recognize Tlg1p and Vti1p were a gift from J. Coe (IMCB, Singapore) and W. Hong (IMCB, Singapore). The monoclonal antibody 16B12, which recognizes the influenza hemagglutinin (HA) epitope, was purchased from BabCo.

Plasmids
--------

All DNA manipulations were performed using routine procedures. Plasmid pEG111, provided by E. Grote (Yale University, New Haven, CT) is an integrating vector encoding an HA-epitope--tagged version of Snc2p ([@bib1]). pNOz10 was constructed by subcloning a BamHI-HindII fragment encompassing the tagged Snc2p coding sequence from pEG111 into pRS306 ([@bib25]).

Strains
-------

All yeast strains used in these studies are described in [Table I](#tbl1){ref-type="table"}. Yeast strains were constructed using standard genetic techniques and grown in rich media (YEPD; 1% yeast extract, 1% peptone, 2% dextrose) or standard minimal medium using either glucose, or raffinose and galactose as carbon sources. NOzY21, 22, 23, and 24 all harbor an allele of *SNC2* encoding an HA-tagged version of the v-SNARE ([@bib1]). NOzY21, NOzY23, and NOzY24 were derived from SF838--9D ([@bib24]), PAY704--1, provided by M. Stark (University of Dundee, Dundee, UK; [@bib21]), and SGY79 ([@bib8]), respectively, using pEGIII ([@bib1]). NOzY22 was constructed from SEY5186α, provided by S. Emr (University of California, San Diego, La Jolla, CA), using pNOz10.

###### Yeast strains used in this study

  Strain     Genotype                                                                                         Source
  ---------- ------------------------------------------------------------------------------------------------ ------------
  SF838-9D   MATα ura3-52 leu2-3,112 his4-519 ade6 gal2 pep4-3                                                [@bib24]
  SGY79      MATα ura3-52 leu2-3,112 his4-519 ade6 gal2 pep4-3 vps21Δ::Kan                                    [@bib8]
  NOzY24     MATα ura3-52 leu2-3,112 his4-519 ade6 gal2 pep4-3 vps21Δ::Kan SNC2::\[LEU2, GAL1-SNC2-HA\]       This study
  NOzY21     MATα ura3-52 leu2-3,112 his4-519 ade6 gal2 pep4-3 SNC2::\[LEU2, GAL1-SNC2-HA\]                   This study
  NOzY22     MATα ura3-52 leu2-3,112 sec18-1 gal2 SNC2::\[LEU2, GAL1-SNC2-HA\]                                This study
  PAY704-1   MAT**a** ade2-1 his3-11,15 leu2-3,112 ura3-1 glc7::LEU2 trp1-1::glc7-10::TRP1 can1-100 ssd1-d2   [@bib21]

Subcellular fractionation
-------------------------

Cells were fractionated using differential centrifugation after osmotic lysis as described previously ([@bib2]). Before any described temperature shifts, cells were grown in 10 ml YEPD to mid-log phase. The amount of Vps45p in each fraction was assessed using immunoblot analysis. Band intensities were quantified by densitometry using a scanning densitometer (Bio-Rad Laboratories) and NIH Image software.

SNARE complex immunoprecipitations
----------------------------------

Tlg1p- and Tlg2p-containing complexes were immunoprecipitated from solubilized membranes as described previously ([@bib1]; [@bib2]). Precipitated proteins were detected using immunoblot analysis. Band intensities were quantified by densitometry using a scanning densitometer (Bio-Rad Laboratories) and NIH Image software.

Metabolic labeling and pulse-chase immunoprecipitation of CPY
-------------------------------------------------------------

The fate of newly synthesized CPY in *glc7--10* cells was followed by immunoprecipitation of the protein as described previously ([@bib2]).
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